Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 626 - 650 of 813 in total

Acetoacetyl-CoA

Experimental

Dodecyl-Coa

Experimental

5-Mercaptoethanol-2-decenoyl-coenzyme A

Experimental

Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid

A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. [PubChem]
Experimental

5-beta-D-ribofuranosylnicotinamide adenine dinucleotide

Experimental

Selenazole-4-carboxyamide-adenine dinucleotide

Experimental

5,10-Dimethylene Tetrahydromethanopterin

Experimental

{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid

Experimental

Hexanoyl-CoA

Experimental

Octanoyl-Coenzyme A

Experimental

2-carboxypropyl-coenzyme A

Experimental

(R)-3-hydroxydecanoyl-CoA

Experimental

3-thiaoctanoyl-CoA

Experimental

4-hydroxybenzyl coenzyme A

Experimental

5,6-dihydroxy-NADP

Experimental

1,2-diacyl-sn-glycero-3-phosphoinositol

Experimental

2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide

Experimental

8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide

Experimental

Thionicotinamide-Adenine-Dinucleotide

Experimental

4-phospho-D-erythronic acid

Experimental

Carboxylic PRPP

Experimental

Amrubicin

Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...
Investigational

PAS219

Experimental

4-hydroxyphenacyl coenzyme A

Experimental

(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate

Experimental
Displaying drugs 626 - 650 of 813 in total